- Home
- PBA vs BNTX Comparison
PBA vs BNTX Comparison
Compare PBA & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBA
- BNTX
- Stock Information
- Founded
- PBA 1997
- BNTX 2008
- Country
- PBA Canada
- BNTX Germany
- Employees
- PBA N/A
- BNTX N/A
- Industry
- PBA Oil & Gas Production
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PBA Energy
- BNTX Health Care
- Exchange
- PBA Nasdaq
- BNTX Nasdaq
- Market Cap
- PBA 24.0B
- BNTX 23.9B
- IPO Year
- PBA N/A
- BNTX 2019
- Fundamental
- Price
- PBA $36.57
- BNTX $113.77
- Analyst Decision
- PBA Buy
- BNTX Strong Buy
- Analyst Count
- PBA 1
- BNTX 15
- Target Price
- PBA $57.00
- BNTX $143.50
- AVG Volume (30 Days)
- PBA 1.5M
- BNTX 630.9K
- Earning Date
- PBA 02-20-2025
- BNTX 11-04-2024
- Dividend Yield
- PBA 5.30%
- BNTX N/A
- EPS Growth
- PBA 51.43
- BNTX N/A
- EPS
- PBA 2.43
- BNTX N/A
- Revenue
- PBA $7,305,229,650.00
- BNTX $3,390,698,192.00
- Revenue This Year
- PBA N/A
- BNTX N/A
- Revenue Next Year
- PBA $15.54
- BNTX N/A
- P/E Ratio
- PBA $15.08
- BNTX N/A
- Revenue Growth
- PBA 37.18
- BNTX N/A
- 52 Week Low
- PBA $32.81
- BNTX $76.53
- 52 Week High
- PBA $43.44
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- PBA 28.81
- BNTX 48.60
- Support Level
- PBA $38.75
- BNTX $109.52
- Resistance Level
- PBA $36.99
- BNTX $115.34
- Average True Range (ATR)
- PBA 0.65
- BNTX 4.35
- MACD
- PBA -0.13
- BNTX -0.72
- Stochastic Oscillator
- PBA 17.95
- BNTX 26.76
About PBA Pembina Pipeline Corp. (Canada)
Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its assets include pipelines and gas gathering as well as assets across fractionation, storage, and propane exports.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.